Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-131X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis ; volume:36 ; number:2 ; day:8 ; month:1 ; year:2019 ; pages:1-6 ; date:2.2019
Medical oncology ; 36, Heft 2 (8.1.2019), 1-6, 2.2019
- Urheber
-
Helbig, Grzegorz
Wieczorkiewicz-Kabut, Agata
Markiewicz, Mirosław
Krzemień, Helena
Wójciak, Michał
Białas, Krzysztof
Kopera, Małgorzata
Rzenno, Ewa
Woźniczka, Krzysztof
Kopińska, Anna
Grygoruk-Wiśniowska, Iwona
Koclęga, Anna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12032-019-1245-5
- URN
-
urn:nbn:de:101:1-2019030623341693738257
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Helbig, Grzegorz
- Wieczorkiewicz-Kabut, Agata
- Markiewicz, Mirosław
- Krzemień, Helena
- Wójciak, Michał
- Białas, Krzysztof
- Kopera, Małgorzata
- Rzenno, Ewa
- Woźniczka, Krzysztof
- Kopińska, Anna
- Grygoruk-Wiśniowska, Iwona
- Koclęga, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Importance of allogeneic stem cell transplantation in myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Splenic re-irradiation for waldenstrőm’s macroglobulinemia
Myelofibrosis
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
Risk factors for allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: a study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Importance of allogeneic stem cell transplantation in myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Splenic re-irradiation for waldenstrőm’s macroglobulinemia
Myelofibrosis
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
Risk factors for allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: a study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Importance of allogeneic stem cell transplantation in myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Splenic re-irradiation for waldenstrőm’s macroglobulinemia
Myelofibrosis
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
Risk factors for allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: a study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry